Additionally, a cohort study with a sample size of 3,265 patients showed that SAA could serve as a biomarker for COVID-19 prognosis as SAA level > 12.4 mg/L showed increased risk of death using Kaplan–Meier survival curves (54). This evidence concerns the gene SAA1 and COVID-19.